1. 1) Jeon O.-C., Seo D.-H., Kim H.-S., Byun Y., Park J. W., Eur. J. Pharm. Sci., 82, 1–10 (2016).
2. 2) Thar Pharmaceuticals, Inc. A METHOD FOR INCREASING THE AQUEOUS SOLUBILITY OF A BISPHOSPHONIC ACID OR A BISPHOSPHONATE. Europe; EP3158867A1, 2017
3. 3) Dr Reddy’s Laboratories Ltd. CRYSTALLINE FORM OF ZOLEDRONIC ACD. United states; US2006/0178439 A1, 2006.
4. 4) Merrion Research I Limited. SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER. United states; US2007/0196464 A1, 2007.
5. 5) Desiraju G. R., ChemInform, 39, no–no (2008).